Your browser doesn't support javascript.
loading
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.
Isenberg, D A; Petri, M; Kalunian, K; Tanaka, Y; Urowitz, M B; Hoffman, R W; Morgan-Cox, M; Iikuni, N; Silk, M; Wallace, D J.
Afiliação
  • Isenberg DA; University College Hospital to University College London, London, UK.
  • Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kalunian K; Division of Rheumatology, Allergy and Immunology, UCSD School of Medicine, La Jolla, California, USA.
  • Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
  • Urowitz MB; University of Toronto, Toronto Western Hospital, Toronto, Canada.
  • Hoffman RW; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Morgan-Cox M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Iikuni N; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Silk M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Wallace DJ; Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Ann Rheum Dis ; 75(2): 323-31, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26338095
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Ativador de Células B / Lúpus Eritematoso Sistêmico / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Ativador de Células B / Lúpus Eritematoso Sistêmico / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2016 Tipo de documento: Article